Tigers Head To Texas With Momentum About To Be Tested

The Detroit Tigers, riding high after a series sweep against the Yankees, face a tough test as they visit the Texas Rangers, tied for the top of their division.

The Detroit Tigers head into Texas riding the momentum of a sweep in the Bronx, and now they get a new test: a three-game set against the Rangers, starting Thursday night at Globe Life Field.

Detroit wrapped up its second straight month with a 6-2 win over the New York Yankees on Wednesday afternoon. Troy Melton set the tone with 6 1/3 innings of two-hit ball, and even though the bullpen gave up another save, the Tigers still broke things open with a four-run 11th to finish the job.

Now AJ Hinch’s club stays on the road and opens the series against a Rangers team tied for first in the AL West. Detroit will send left-hander Framber Valdez to the mound in the opener.

The 32-year-old turned in a solid June across five starts, posting a 3.21 ERA and 4.14 FIP. Three of those outings were one-run efforts, while the other two saw him give up four runs apiece.

Texas counters with Nathan Eovaldi, who is coming off his best start of the month. The right-hander threw seven shutout innings last time out, allowing five hits and a walk while striking out nine.

Before that, though, June had been a tougher stretch for the 36-year-old, who carried a 5.11 ERA and 4.04 FIP across his other four starts of the month. In that 24 1/3-inning span, he gave up four home runs and struck out 25.

On paper, the matchup in Thursday night’s opener features two pitchers with similar underlying numbers, even if their recent paths have looked different. Valdez enters Game 88 at 4-5 with a 4.05 ERA, while Eovaldi comes in at 8-7 with a 3.95 ERA.

Valdez has 95.2 innings, an 18.5 percent strikeout rate, an 8.2 percent walk rate, a 52.2 percent ground-ball rate, a 4.17 FIP and 1.0 fWAR. Eovaldi has logged 100.1 innings, with a 24.4 percent strikeout rate, a 5.6 percent walk rate, a 50.2 percent ground-ball rate, a 4.16 FIP and 1.3 fWAR.

In Other News...

Tigers Fans Wont Like The Latest Trade Rumor Around Their Ace

Tarik Skubals return to the mound has been one of the bright spots of the Tigers season, especially after he came back from elbow surgery and quickly looked like himself again. In 11 starts, the two-time American League Cy Young winner has posted a 3.15 ERA, a reminder of why Detroit has leaned so heavily on him as the anchor of its rotation.

Now, though, the conversation around Skubal is drifting far beyond his next outing. With the 2026 trade deadline still ahead, his name has surfaced in chatter among multiple clubs, a familiar kind of noise for an ace of his stature but one Tigers fans would rather not hear attached to a pitcher who has already proved how valuable he can be. [Read more 🡒]

Tigers Season Somehow Has One Split That Makes No Sense

For a club that has spent much of the summer looking up in the standings, the Tigers have collected a few odd side stories along the way. Detroit sits 37-49 and 12th in the American League, still six games back of the final Wild Card spot, but the shape of its season has been anything but routine. The Tigers have been sturdier in day games, have held their own more often at Comerica Park than on the road, and have had a strangely sharp contrast against starting-pitcher handedness.

The bigger head-scratcher is how uneven Detroit has been inside the AL Central, where the losses have piled up and kept the club from gaining any traction in the division race. Even as the Tigers have found ways to compete in some spots, the profile keeps pointing to a team that is more comfortable in certain settings than others, and the split against left-handed starters only adds another layer to the puzzle. For a roster trying to stay in the hunt, the next challenge is figuring out which version of the Tigers is the real one. [Read more 🡒]

Jackson Jobe Just Gave Tigers Fans A Reason To Dream Again

Jackson Jobes rehab has moved from a long-term hope to something a lot more tangible for Tigers fans. After Tommy John surgery in June 2025, the right-hander has kept stacking milestones, from offseason work in Texas to spring training time in Lakeland and bullpen sessions that showed he was trending in the right direction. The progress has been steady enough that team sources and MLB.com have both confirmed his velocity is back in a big way as he works his way through the next phase.

What makes the buildup matter is not just the radar-gun reading, but what it says about the shape of Jobes recovery. He has already cleared bullpen work, and if the rest of the rehab keeps moving cleanly, Detroit can start imagining him as part of the 2026 rotation picture. For a club that has been waiting to see whether one of its top arms could come back on schedule, that kind of progress is enough to keep the conversation alive all summer. [Read more 🡒]